On this episode of The Open Mind, we're delighted to welcome Charles Graeber, an award winning science journalist and contributor to myriad publications including the New Yorker, National Geographic, MIT Technology Reviewand Wiredfor which he is a contributing editor. His new book, “The Breakthrough: Immunotherapy and the Race to Cure Cancer” probes the treatment that aspires to make cancer chronic instead of fatal and ultimately to beat it forever.
Dr. James Gulley, director of medical oncology, chief of immunology at the National Cancer Institute and National Institutes of Health calls “The Breakthrough” a must read. “It not only provides good background and good understanding for patients, but it's also a wonderful read, easily picked up but not easily put down. I'd recommend it for any patient interested in immunotherapy of cancer.” In Graeber’s own words, “Immunotherapy is the only approach to cancer that could actually curate it: a mutating answer to a mutating problem.”
